Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10076581 Deuterated compounds and uses thereof

Patent 10076581 was granted and assigned to Genentech on September, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10076581

Date of Patent

September 18, 2018

Patent Application Number

15006997

Date Filed

January 26, 2016

Patent Citations Received

‌

US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

‌

US Patent 11504440 Deuterated compounds

‌

US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

‌

US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

‌

US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

Patent Primary Examiner

‌

Michael G. Hartley

Patent abstract

The present invention relates to deuterated and optionally detectably labeled compounds of formula (I) and formula (V):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10076581 Deuterated compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API